Socioeconomic Issues and the Transplant Recipient

  • Mary Beth Callahan
  • Connie L. Davis


Socioeconomic status (SES), a composite variable based on education, income, and occupation, has long been a prime predictive variable of clinical outcomes. SES determines access to care and can contribute to non-adherence when people have to make choices between health care and basic needs. Lower life expectancy and higher mortality rates are linked with SES.


Chronic Kidney Disease Transplant Recipient Kidney Transplant Vocational Rehabilitation Transplant Center 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Evans R. Non-Adherence in the Transplant Patient. National Institutes of Health conference, January 2008, Tampa, FL, 2008.Google Scholar
  2. 2.
    World Health Organization, . Adherence to Long-Term Therapies. World Health Organization, Geneva, 2001.Google Scholar
  3. 3.
    Gratwohl A, Dohler B, Stern M, Opelz G. H-Y as a minor histocompatibility antigen in kidney transplantation: a retrospective cohort study. Lancet 2008 July 5;372(9632):49–53.CrossRefPubMedGoogle Scholar
  4. 4.
    Oh CK, Jeon KO, Kim HJ, Kim SI, Kim YS, Pelletier SJ. Metabolic demand and renal mass supply affecting the early graft function after living donor kidney transplantation. Kidney Int 2005 Feb;67(2):744–749.CrossRefPubMedGoogle Scholar
  5. 5.
    Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003 Feb;3(2):178–185.CrossRefPubMedGoogle Scholar
  6. 6.
    Keith DS, Cantarovich M, Paraskevas S, Tchervenkov J. Recipient age and risk of chronic allograft nephropathy in primary deceased donor kidney transplant. Transpl Int 2006 Aug;19(8):649–656.CrossRefPubMedGoogle Scholar
  7. 7.
    Ashby VB, Kalbfleisch JD, Wolfe RA, Lin MJ, Port FK, Leichtman AB. Geographic variability in access to primary kidney transplantation in the United States, 1996–2005. Am J Transplant 2007;7(Suppl 1):1412–1423.CrossRefPubMedGoogle Scholar
  8. 8.
    Abecassis M, Bartlett ST, Collins AJ et al. Kidney transplantation as primary therapy for end stage renal disease: Proceedings of a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative Conference. Clin J Am Soc Nephrol 2008;3(2):471–480.CrossRefPubMedGoogle Scholar
  9. 9.
    aakpRENALIFE. She focuses on the present and remembers the past. aakpRENALIFE 2002 May;17(6).Google Scholar
  10. 10.
    White SL, McGeechan K, Jones M, Cass A, Chadban SJ, Polkinghorne KR, Perkovic V, Roderick PJ. Socioeconomic disadvantage and kidney disease in the United States, Australia, and Thailand. Am J Public Health 2008 Jul;98(7)1306–1313. E-pub 2008.CrossRefPubMedGoogle Scholar
  11. 11.
    National Kidney Foundation/Council of Nephrology Social Workers Pediatric Toolkit, 2008.Google Scholar
  12. 12.
    Kutner N, Bowles T, Zhang R, Huang Y, Pastan S. Dialysis facility characteristics and variation in employment rates: A National Study. Clin J Am Soc Nephrol 2008 Jan;3(1):111–116.CrossRefPubMedGoogle Scholar
  13. 13.
    O’Sullivan D, McCarthy G. An exploration of the relationship between fatigue and physical functioning in patients with end stage renal disease receiving haemodialysis. J Clin Nurs 2007 Nov;16(11C):276–284.CrossRefPubMedGoogle Scholar
  14. 14.
    Navaneethan SD, Singh S. A systematic review of barriers in access to renal transplantation among African Americans in the United States. Clin Transplant 2006 Nov–Dec;20(6):769–775.CrossRefPubMedGoogle Scholar
  15. 15.
    Shilling LM, Norman ML, Chavin KD, Hildebrand LG, Lunsford SL, Martin MS, Milton JE, Smalls GR, Baliga PK. Healthcare professionals’ perceptions of the barriers to living donor kidney transplantation among African Americans. J Natl Med Assoc 2006 Jun;98(6):834–840.PubMedGoogle Scholar
  16. 16.
    Ayanian JZ, Cleary PD, Weissman JS, Epstein AM. The effect of patients’ preferences on racial differences in access to renal transplantation. N Engl J Med 1999 Nov 25;341(22):1661–1669.CrossRefPubMedGoogle Scholar
  17. 17.
    Russell CL. Culturally responsive interventions to enhance immunosuppressive medication adherence in older African American kidney transplant recipients. Prog Transplant 2006 Sep;16(3)187–195. quiz 196.PubMedGoogle Scholar
  18. 18.
    Shemesh E, Annunziato RA, Shneider BL, Dugan CA, Warshaw J, Kerkar N, Emre S. Improving adherence to medications in pediatric liver transplant recipients. Pediatr Transplant 2008 May;12(3):316–323.CrossRefPubMedGoogle Scholar
  19. 19.
    Berquist RK, Berquist WE, Esquivel CO, Cox KL, Wayman KI, Litt IF. Non-adherence to post-transplant care: prevalence, risk factors and outcomes in adolescent liver transplant recipients. Pediatr Transplant 2008 Mar;12(2):194–200.CrossRefPubMedGoogle Scholar
  20. 20.
    Orr A, Orr D, Willis S, Holmes M, Britton P. Patient perceptions of factors influencing adherence to medication following kidney transplant. Psychol Health Med 2007 Aug;12(4):509–517.CrossRefPubMedGoogle Scholar
  21. 21.
    Henderson AJ, Landolt MA, McDonald MF, Barrable WM, Soos JG, Gourlay W, Allison CJ, Landsberg DN. The living anonymous kidney donor: lunatic or saint? Am J Transplant 2003 Feb;3(2):203–213.CrossRefPubMedGoogle Scholar
  22. 22.
    Manauis MN, Pilar KA, Lesaca R, de Belen Uriarte R, Danguilan R, Ona E. A national program for nondirected kidney donation from living unrelated donors: the Philippine experience. Transplant Proc 2008 Sep;40(7):2100–2103.CrossRefPubMedGoogle Scholar
  23. 23.
    Reimer J, Rensing A, Haasen C, Philipp T, Pietruck F, Franke GH. The impact of living-related kidney transplantation on the donor’s life. Transplantation 2006 May 15;81(9):1268–1273.CrossRefPubMedGoogle Scholar
  24. 24.
    McCune TR, Armata T, Mendez-Picon G, Yium J, Zabari GB, Crandall B, Spicer HG, Blanton J, Thacker LR. The living organ donor network: a model registry for living kidney donors. Clin Transplant 2004;18(Suppl 12):33–38.CrossRefPubMedGoogle Scholar
  25. 25.
    Clarke KS, Klarenbach S, Vlaicu S, Yang RC, Garg AX. The direct and indirect economic costs incurred by living kidney donors—a systematic review. Nephrol Dial Transplant 2006 July;21(7)1952–1960. E-pub 2006 Mar 22.CrossRefPubMedGoogle Scholar
  26. 26.
    Gill J, Madhira BR, Gjertson D, Lipshutz G, Cecka JM, Pham PT, Wilkinson A, Bunnapradist S, Danovitch GM. Transplant tourism in the United States: a single-center experience. Clin J Am Soc Nephrol 2008 Nov;3(6)1820–1828. E-pub 2008 Oct 1.CrossRefPubMedGoogle Scholar
  27. 27.
    Budiani-Saberi DA, Delmonico FL. Organ trafficking and transplant tourism: a commentary on the global realities. Am J Transplant 2008 May;8(5):925–929.CrossRefPubMedGoogle Scholar
  28. 28.
    Rizvi SA, Naqvi SA, Zafar MN, Mazhar F, Muzaffar R, Naqvi R, Akhtar F, Ahmed E. Commercial transplants in local Pakistanis from vended kidneys: a socio-economic and outcome study. Transpl Int 2009 Jan 31;22(6):615–621.CrossRefPubMedGoogle Scholar
  29. 29.
    Naqvi SA, Rizvi SA, Zafar MN, Ahmed E, Ali B, Mehmood K, Awan MJ, Mubarak B, Mazhar F. Health status and renal function evaluation of kidney vendors: a report from Pakistan. Am J Transplant 2008 Jul;8(7):1444–1450.CrossRefPubMedGoogle Scholar
  30. 30.
    Steering Committee of the Istanbul Summit. Organ trafficking and transplant tourism and commercialism: the Declaration of Istanbul. Lancet 2008 Jul;5(372):963.Google Scholar
  31. 31.
    Nejatisafa AA, Mortaz-Hedjri S, Malakoutian T, Arbabi M, Hakemi MS, Haghighi AN, Mohammadi MR, Fazel I. Quality of life and life events of living unrelated kidney donors in Iran: a multicenter study. Transplantation 2008 Oct 15;86(7):937–940.CrossRefPubMedGoogle Scholar
  32. 32.
    Barsoum RS. Trends in unrelated-donor kidney transplantation in the developing world. Pediatr Nephrol 2008 Nov;23(11)1925–1929. E-pub 2008 Jun 7.CrossRefPubMedGoogle Scholar
  33. 33.
    Einollahi B, Taheri S. Renal transplantation practice in Iran and the Middle East: report from Iran and a review of the literature. Ann Transplant 2008;13(1)5–14. PMID: 18344938 PubMed.PubMedGoogle Scholar
  34. 34.
    Ghods AJ, Savaj S. Iranian model of paid and regulated living-unrelated kidney donation. Clin J Am Soc Nephrol 2006 Nov;1(6)1136–1145. E-pub 2006 Oct 11.CrossRefPubMedGoogle Scholar
  35. 35.
    Björnsson E, Olsson J, Rydell A, Fredriksson K, Eriksson C, Sjöberg C, Olausson M, Bäckman L, Castedal M, Friman S. Long-term follow-up of patients with alcoholic liver disease after liver transplantation in Sweden: impact of structured management on recidivism. Scand J Gastroenterol 2005 Feb;40(2):206–216.CrossRefPubMedGoogle Scholar
  36. 36.
    Nickels M, Jain A, Sharma R, Orloff M, Tsoulfas G, Kashyap R, Bozorgzadeh A. Polysubstance abuse in liver transplant patients and its impact on survival outcome. Exp Clin Transplant 2007 Dec;5(2):680–685.PubMedGoogle Scholar
  37. 37.
    Lentine KL, Rocca-Rey LA, Bacchi G, Wasi N, Schmitz L, Salvalaggio PR, Abbott KC, Schnitzler MA, Neri L, Brennan DC. Obesity and cardiac risk after kidney transplantation: experience at one center and comprehensive literature review. Transplantation 2008 Jul 27;86(2):303–312.CrossRefPubMedGoogle Scholar
  38. 38.
    Painter PL, Topp KS, Krasnoff JB, Adey D, Strasner A, Tomlanovich S, Stock P. Health-related fitness and quality of life following steroid withdrawal in renal transplant recipients. Kidney Int 2003 Jun;63(6):2309–2316.CrossRefPubMedGoogle Scholar
  39. 39.
    Ibels LS, Stewart JH, Mahony JF, Neale FC, Sheil AG. Occlusive arterial disease in uraemic and haemodialysis patients and renal transplant recipients. A study of the incidence of arterial disease and of the prevalence of risk factors implicated in the pathogenesis of arteriosclerosis. Q J Med 1977 Apr;46(182):197–214.PubMedGoogle Scholar
  40. 40.
    Watnick S, Kirwin P, Mahnensmith R, Concato J. The prevalence and treatment of depression among patients starting dialysis. Am J. Kidney Dis 2003;41(1):105–110.CrossRefPubMedGoogle Scholar
  41. 41.
    McClellan W, Stanwyck D, Anson C. Social support and subsequent mortality among patients with end-stage renal disease. J Am Soc Nephrol 1993;4:1028–1034.PubMedGoogle Scholar
  42. 42.
    Cohen, S & Syme, S (eds). Social Support and Health. Academic Press, Orlando, FL, 1985.Google Scholar

Copyright information

© Springer-Verlag US 2010

Authors and Affiliations

  1. 1.Dallas Transplant InstituteDallasUSA
  2. 2.Department of MedicineUniversity of WashingtonSeattleUSA

Personalised recommendations